KKR Real Estate Finance Trust Inc.

What they do

KREF originates and acquires transitional senior loans secured by institutional-quality commercial real estate, plus mezzanine loans, preferred equity and CMBS. It is externally managed by KKR Real Estate Finance Manager LLC, an indirect subsidiary of KKR, and operates as a single reporting segment. The company is structured as a REIT and relies on KKR Real Estate's roughly 130 real estate professionals for sourcing and underwriting.

Revenue drivers

• Senior loan interest income — The core book is floating-rate senior loans; the portfolio was $4.5 billion at June 30, 2026, with a weighted average unlevered all-in yield of 6.8% and 98% floating-rate exposure.
• Loan originations and repayments — In Q2 2026 KREF committed $348.6 million and funded $328.3 million across three floating-rate loans, while receiving $806.6 million of repayments including $784.2 million of full repayments.
• Property-type concentration — Multifamily and industrial assets represented 60% of the loan portfolio at June 30, 2026, with a weighted average origination LTV of 66%.

Recent performance

Q2 2026 net loss attributable to common stockholders was $121.8 million, or $1.95 per diluted share, versus a $61.9 million loss ($0.96 per share) in Q1 2026. Distributable Loss was $36.4 million ($0.58 per share) in Q2 2026, compared with $4.1 million ($0.06 per share) in Q1 2026. The quarter included a $119.8 million increase in the loan loss allowance, or $1.92 per share, tied mainly to risk-rated 5 and held-for-sale loans. Common book value was $604.0 million, or $10.24 per share, at June 30, 2026. The company repurchased 5.7 million shares at an average $6.63 for $38.0 million.

Strategy

Management says it is executing the action plan set at the beginning of the year while the Board reviews strategic alternatives. The company is repositioning the portfolio by resolving watchlist loans and generating liquidity through repayments; in Q2 2026 it resolved two watchlist loans, taking title to a Boston life science property on a risk-rated 5 loan and receiving repayment on a risk-rated 4 loan in Georgetown, TX. Financing strategy emphasizes non-mark-to-market facilities, including two new European facilities with commitments of 115 million and 99 million. Management reports $721.6 million of liquidity, over $2 billion of expected 2026 repayments, and no final facility maturities until 2027 and no corporate debt due until 2030.

Risks

• Credit deterioration — The Q2 2026 allowance increase of $119.8 million was driven primarily by additional reserves on risk-rated 5 and held-for-sale loans, and the portfolio carries an average risk rating of 3.3.
• Office exposure — The 10-Q cites lower office demand and elevated vacancy and default rates as challenges; KREF also originated an office loan in California during Q2 2026.
• Interest rate and spread risk — Higher rates can pressure borrowers' refinancing costs and property values and raise KREF's own interest expense, which may not be offset by higher interest income.
• Competition for loans — The 10-K notes competition from other REITs, specialty finance companies, and KKR-affiliated funds, with some competitors having lower cost of funds and fewer REIT or Investment Company Act constraints.

Outlook

Management points to $721.6 million of liquidity, over $2 billion of expected repayments in 2026, and predominantly non-mark-to-market financing as the basis for navigating the action plan. The Board's review of strategic alternatives remains pending, per CEO Matt Salem's remarks. No final facility maturities are due until 2027 and no corporate debt until 2030.